Unifeye Vision Partners Announces CEO Transition: Appoints Mark Garvin as Chief Executive Officer to Succeed Martin Rash

29.09.25 16:00 Uhr

DALLAS, Sept. 29, 2025 /PRNewswire/ -- Unifeye Vision Partners ("UVP" or the "Company"), an operator of ambulatory surgery centers ("ASCs") with supporting practice management services in the ophthalmology industry, today announced the appointment of Mark Garvin as Chief Executive Officer. Mr. Garvin succeeds Martin Rash, who will remain with UVP as Executive Chairman of the Board of Directors.

Waud Capital Partners (PRNewsfoto/Waud Capital Partners)

Mr. Garvin brings over 30 years of experience in the healthcare industry, including most recently at Banner Health and previously at United Surgical Partners International ("USPI"). During his nearly 20-year tenure at USPI, he helped lead the business through multiple transformational growth periods through organic and inorganic growth methods to ultimately become one of the largest ASC operators in the country.

"I'm honored to join UVP and partner with physicians and our teammates to expand patient access, enhance the overall experience, and grow our integrated ASC and clinic presence in existing and new markets," said Mr. Garvin. "We will focus on measurable outcomes, operational excellence, talent growth and a differentiated patient experience to deliver value for all key stakeholders across the organization."

"The Board is excited to welcome Mark to UVP at an exciting time in the company's evolution," said Chris Graber, Partner and Head of Healthcare with Waud Capital Partners, UVP's founding investor. "Marty helped lead the Company successfully during a period of significant growth, and the business is in a strong position today because of his great leadership. " Martin Rash commented, "I'm delighted to welcome Mark to the team. He has built his career supporting physicians through ASC growth, operational improvement and physician recruitment. We are excited to have Mark lead this next phase of growth for UVP."

Under Mr. Garvin's leadership, UVP will continue to support the growth of comprehensive eye care practices through ASC development and optimization, as well as physician recruitment, operational improvements and service expansion, aligning with the company's mission to improve care and access in ambulatory settings.

About Unifeye Vision Partners

UVP is a physician-led ambulatory surgery center operator with integrated practice management services focused on ophthalmology. The company delivers comprehensive management and support services to ophthalmology and optometry practices, as well as single-specialty eye surgery centers. Today UVP supports a network of 66 clinic locations and 19 ambulatory surgery centers. For more information, visit www.uvpeye.com.

About Waud Capital Partners

Based in Chicago and founded by Reeve B. Waud, Waud Capital Partners is a growth-oriented private equity firm with over 30 years of investing experience. Waud Capital Partners seeks to partner with experienced management teams to build market-leading companies within two industries: healthcare and software & technology. Since its founding in 1993, Waud Capital has successfully completed more than 500 investments, including platform companies and follow-on opportunities. For additional information on Waud Capital, please visit www.waudcapital.com.

For Further Information and Inquiries:

Mark Garvin, CEO

Unifeye Vision Partners

Mark.garvin@uvpeye.com

Mike Lehman, Principal

Waud Capital Partners

(312) 676-8400

mlehman@waudcapital.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/unifeye-vision-partners-announces-ceo-transition-appoints-mark-garvin-as-chief-executive-officer-to-succeed-martin-rash-302569088.html

SOURCE Waud Capital Partners